Labsystems Diagnostics' Neonatal Biotinidase kit is for enzymatic determination of biotinidase enzyme activity from blood samples dried on filter paper, with fluorometric detection, intended for newborn screening for biotinidase deficiency.
Labsystems Diagnostics' Neonatal G6PD is an enzymatic method for the quantitative determination of glucose-6-phosphate dehydrogenase activity in blood samples dried on filter paper, with fluorometric detection, intended for newborn screening of glucose-6-phosphate dehydrogenase deficiency.
Labsystems Diagnostics' Neonatal Galactose is a quantitative fluorometric test for the total galactose from dried blood spot samples. The test is based on the combined determination of free and galactose liberated from the cleavage of the galactose-1-phosphate.
Labsystems Diagnostics' test is designed for the quantitative in vitro determination of galactose-1-phosphate uridyltransferase (GALT) activity in blood samples dried on filter paper. This kit is intended for screening newborns for classic galactosemia, which is caused by the inability to convert Galactose-1-phosphate into glucose-1-phosphate due to GALT deficiency.
Labsystems Diagnostics' Neonatal Phenylalanine is a chemical method, with fluorometric detection, for quantitative determination of phenylalanine from blood specimens dried on filter paper, intended for newborn screening for phenylketonuria (PKU).
- Real time-PCR based kit
- DNA Samples from whole blood or Dried Blood Spots can be used
- Detects both SCIO (TREC/KREC) and SMA (SMN l /SMN2) Simultaneously
- Three levels of control
- Less processing time ( 1 .5 hours for PCR, excluding DNA isolations)
To run a successful and cost-effective newborn screening test, there is a requirement for all the instruments and reagents. Trivitron's Labsystems Diagnostics Oy delivers the most sophisticated fully-automated solutions in the highest quality and performance standards, ensuring the highest levels of performance for your lab.